Msd

Dhoni retired from Test cricket in 2014 and stepped away from ODIs and T20Is in 2020, though he has continued to play in the IPL.

Ruturaj Gaikwad: Profile, career info and achievements

IPL 2024: Ruturaj Gaikwad has been named as captain of Chennai Super Kings (CSK) after Dhoni stepped down as skipper just a day ahead of the start of T20 league.

Chennai Super Kings team: Top 5 bowlers to watch out for in IPL 2024

Indian Premiere League (IPL) 2024: Defending champions Chennai Super Kings (CSK) will take on Royal Challengers Bangalore in the opener match of the tournament. Let's take a look at their bowling line up with top performers in last season of IPL.

Chennai Super Kings team: Top 5 batsman to watch out for in IPL 2024

Indian Premier League 2024: Five-time winners and defending champions, Chennai Super Kings (CSK), will go in the IPL 2024 with a formidable batting unit. Let's take a look at their top performers in the last season.

Dhoni masterminds CSK’s 10th entry into IPL final

Defending champions Gujarat Titans, defeated by 15 runs in Qualifier 1 by CSK, have one more chance to enter a second consecutive final when they play in Qualifier 2 on May 26.

Global pharma companies pushing to innovate in India: OPPI president

The industry body says it is collaborating, converging and co-creating with the government and other stakeholders to enable an innovative environment in India

India vs Australia: Sachin Tendulkar expects Dhoni to 'anchor' and 'control' the game now

The Master Blaster in an interview on his official app 100MB also spoke about how other team members are performing well and urged fans to support newcomers

IPL 2018: MS 'Finisher' Dhoni is back; bowlers beware

With six unbeaten knocks, Dhoni is having the best IPL of his life. An average of 90 proves that his finishing touch is back.

Zydus Cadila acquires 6 brands from global pharma major MSD

Drug firm Zydus Cadila today said it has acquired six brands from global pharma major MSD and its subsidiaries for an undisclosed amount.

Merck drops India from Priority market list

US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.

Lupin to co-market MSD's pneumonia vaccine in India

Lupin gets a non-exclusive license to market MSD's pneumococcal polysaccharide vaccine under a different brand name in India.

Sun Pharma in pact with MSD; stock down

Sun Pharmaceutical Industries is in pact with MSD to co-market diabetes drugs in India, reports CNBC-TV18. It touched an intraday high of Rs 449 and an intraday low of Rs 444. At 10:33 hrs the share was quoting at Rs 445, down Rs 0.80, or 0.18%.